4/28/2010

Japanese drug company Astellas Pharma is slated to break ground on a $150 million corporate campus in Chicago's suburbs. Experts say the company got a deal: Development of the campus will cost roughly $150 million, or about 20% less than it would have at the market's high point.

Related Summaries